Breaking Through

TB Alliance Annual Report 2019

A Message from the CEO and Board Chair

We expect to look back on 2019 as a decisive year for TB Alliance.

Read more
CEO letter - breaking through
New pediatric treatments

A New Treatment for Highly Drug-Resistant Forms of TB

Learn more

More Than One Million Child-Friendly Treatment Courses Ordered

The new medicines are easier for caregivers to give and for children to take, and the formulations have now been ordered by more than 90 countries.

Read more
Pretomanid at work

New Therapy Shows Promise of Regimen Development

Treating TB requires a combination of drugs, and advances in therapy had hinged on the development of individual drugs. We developed a new approach.

Learn more

Partnerships in Practice

None of our work would be possible without the continued commitment of our diverse network of partners.

Read more

TB Alliance in 2019

An overview of the milestones TB Alliance achieved toward our goal to develop new, better treatments for all forms of TB.

Annual Report 2019